Fundraising Fox

Mineralys Therapeutics

NASDAQ: MLYS

Radnor, US · Founded 2019 · Incorporated in Delaware · 7 known investors

mineralystx.com ↗
Biotechin /mineralys-therapeutics-inc

Founders & leadership

BT
Brian Taylor SlingsbyDirector
OL
Olivier LitzkaDirector
DD
Derek DiRoccoDirector
AL
Adam LevyExecutive Officer
JC
Jon CongletonExecutive Officer, Director
SA
Srinivas AkkarajuDirector
AA
Alexander AsamDirector
TT
Takeshi TakahashiDirector

Investors · 7

Andera PartnersParis
SR One Capital ManagementRedwood City
Ysios CapitalBarcelona · $5.4M – $21.6M
Boulder VenturesreportedBoulder · $1M – $4M
Catalys PacificreportedTokyovia Brian Taylor Slingsby · board
RA CapitalreportedBostonvia Derek DiRocco · board
Samsara BioCapitalreportedPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$118MraisedJun 2022 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian Taylor SlingsbyDirector
  • Olivier LitzkaDirector
  • Derek DiRoccoDirector
  • Adam LevyExecutive Officer
  • Jon CongletonExecutive Officer, Director
  • Srinivas AkkarajuDirector
  • Alexander AsamDirector
  • Takeshi TakahashiDirector
Offering amount
$118M
Amount sold
$118M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.